Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1980 1
1981 1
1982 1
1983 3
1984 2
1985 5
1986 6
1987 2
1988 5
1989 10
1990 3
1991 8
1992 8
1993 8
1994 14
1995 14
1996 16
1997 21
1998 24
1999 17
2000 38
2001 21
2002 25
2003 19
2004 33
2005 37
2006 28
2007 22
2008 21
2009 19
2010 24
2011 16
2012 23
2013 12
2014 10
2015 13
2016 8
2017 11
2018 9
2019 8
2020 9
2021 6
2022 6
2023 17
2024 26
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

588 results

Results by year

Filters applied: . Clear all
Page 1
Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation.
Zhang Z, Hasegawa Y, Hashimoto D, Senjo H, Kikuchi R, Chen X, Yoneda K, Sekiguchi T, Kawase T, Tsuzuki H, Ishio T, Ara T, Ohigashi H, Nakagawa M, Teshima T. Zhang Z, et al. Among authors: ohigashi h. Bone Marrow Transplant. 2022 May;57(5):775-780. doi: 10.1038/s41409-022-01619-4. Epub 2022 Feb 28. Bone Marrow Transplant. 2022. PMID: 35228711 Free article.
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.
Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, Okada S, Chen X, Kikuchi R, Miyashita N, Onozawa M, Goto H, Endo T, Hasegawa Y, Ohigashi H, Ara T, Hasegawa Y, Murakami M, Teshima T, Hashimoto D. Senjo H, et al. Among authors: ohigashi h. Blood. 2023 Aug 3;142(5):477-492. doi: 10.1182/blood.2023019875. Blood. 2023. PMID: 37216687 Free article.
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.
Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Fuji S, et al. Among authors: ohigashi h. Br J Haematol. 2024 Mar;204(3):959-966. doi: 10.1111/bjh.19228. Epub 2023 Nov 30. Br J Haematol. 2024. PMID: 38037468
Associations between acute and chronic graft-versus-host disease.
Tamaki M, Akahoshi Y, Inamoto Y, Morita K, Uchida N, Doki N, Tanaka M, Nishida T, Ohigashi H, Nakamae H, Onizuka M, Katayama Y, Matsuoka KI, Sawa M, Ishimaru F, Kanda Y, Fukuda T, Atsuta Y, Terakura S, Kanda J. Tamaki M, et al. Among authors: ohigashi h. Blood Adv. 2024 Aug 27;8(16):4250-4261. doi: 10.1182/bloodadvances.2024013442. Blood Adv. 2024. PMID: 38985337 Free PMC article.
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era.
Terao T, Matsuoka KI, Fuji S, Kawamura S, Toya T, Doki N, Uchida N, Tanaka M, Fukuda T, Sawa M, Ishikawa J, Nishida T, Ohigashi H, Maruyama Y, Fujiwara SI, Kanda Y, Ota S, Ishimaru F, Atsuta Y, Kanda J, Ogata M, Yakushijin K, Nakasone H. Terao T, et al. Among authors: ohigashi h. Bone Marrow Transplant. 2024 Sep;59(9):1224-1231. doi: 10.1038/s41409-024-02313-3. Epub 2024 May 25. Bone Marrow Transplant. 2024. PMID: 38796633
Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia.
Shibata S, Arai Y, Kondo T, Mizuno S, Yamasaki S, Akasaka T, Doki N, Ota S, Maruyama Y, Matsuoka KI, Nagafuji K, Eto T, Tanaka T, Ohigashi H, Nakamae H, Onizuka M, Fukuda T, Atsuta Y, Yanada M. Shibata S, et al. Among authors: ohigashi h. Cytotherapy. 2024 Jun;26(6):592-598. doi: 10.1016/j.jcyt.2024.02.010. Epub 2024 Feb 23. Cytotherapy. 2024. PMID: 38466265 Free article.
GVHD targets organoid-forming bile duct stem cells in a TGF-β-dependent manner.
Hasegawa Y, Hashimoto D, Zhang Z, Miyajima T, Saito Y, Li W, Kikuchi R, Senjo H, Sekiguchi T, Tateno T, Chen X, Yokoyama E, Takahashi S, Ohigashi H, Ara T, Hayase E, Yokota I, Teshima T. Hasegawa Y, et al. Among authors: ohigashi h. Blood. 2024 Aug 22;144(8):904-913. doi: 10.1182/blood.2023023060. Blood. 2024. PMID: 38905638
Neurolymphomatosis in Intravascular Large B-cell Lymphoma.
Miyajima T, Ohigashi H, Yaguchi H, Teshima T. Miyajima T, et al. Among authors: ohigashi h. Intern Med. 2023 May 1;62(9):1381-1382. doi: 10.2169/internalmedicine.0021-22. Epub 2022 Oct 5. Intern Med. 2023. PMID: 36198588 Free PMC article. No abstract available.
Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide.
Ido K, Nakamae H, Hattori N, Kanaya M, Morita K, Hino M, Ohigashi H, Fukuda T, Eto T, Nagafuji K, Hiramoto N, Maruyama Y, Ota S, Matsuoka KI, Ando T, Akasaka T, Mori Y, Kamimura T, Kawakita T, Kawamura K, Kanda J, Onizuka M, Atsuta Y, Murata M. Ido K, et al. Among authors: ohigashi h. Br J Haematol. 2024 Sep;205(3):1077-1096. doi: 10.1111/bjh.19630. Epub 2024 Jul 7. Br J Haematol. 2024. PMID: 38972374
588 results